姜春来，吉林大学生命科学学院教授，博士生导师。美国Duke大学Human Vaccine Institute博士后。吉林省药学会生物制品委员会副主任委员；中华医学会医学病毒学委员会青年委员会副主任委员。吉林省拔尖创新人才（第一层次），长春市突出贡献专家。主持国家自然科学基金项目等多项国家级课题。
研究领域为重大传染性疾病的预防（HIV疫苗、手足口病疫苗研究、重组结核病疫苗、HPV疫苗的研究）。在PNAS，Journal of Virology，Vaccine等国际一流期刊以第一作者或通讯作者共发表论文50余篇。作为主要发明人，申请发明专利12项，获得授权7项。
Tutor of Doctor and Professor in the Life Science School of Jilin University, Standing Deputy GM in BCHT Biotechnology Company
Tutor of Doctor and Professor in the Life Science School of Jilin University. Post-doctorate of Human Vaccine Institute in Duke University. Deputy chair committee member of Biologic Products Committee in Jilin Pharmaceutical Society. Deputy chair committee member of Youth Committee of Medical Virus in Chinese Medical Society. Top innovation talent in Jilin, experts with outsourcing contribution. In charge of several state level projects such as state nature science funded projects. His research areas include prevention of major pandemics (HIV vaccine, foot mouth vaccine, recombinant tuberculosis vaccine, HPV vaccine). He published more than 50 papers in global top level periodicals as PNAS, Journal of Virology, Vaccine etc. Filed 12 patents and has been granted with 7 patents as main inventor.